Tijori
Dr. Lal PathLabs Limited
Market Capital
₹ 12,576 Cr.
P/E
54.16
Share Price
₹1511.25 -37.00 (-2.39%)
  • Dr. Lal PathLabs Limited
  • Overview
  • Connections
  • Financials
  • Shareholding
  • Hospital Sector

  • Market Share
  • Revenue Mix
  • About

  • Competitors
  • Investors

  • Price
  • Benchmarking
  • Balance Sheet
  • Profit & Loss
  • Cash Flows
  • Ratios
  • Quarterly Results

  • Overview
  • Trend
  • Detailed

  • Recent News
  • Annual Reports

Market Share
35%
Diagnostic Chains Market Share
Revenue Mix
Distribution Channel
Location Wise Break-Up
Domestic vs Export
Patient Type Break-Up
About
  • DLPL is one of the leading players in pathology services in India. It has a strong brand presence in North India and is increasing its presence in Eastern and Central regions of India.
  • DLPL’s pan-India network currently includes one national reference laboratory (NRL) in Delhi, 190 clinical laboratories, 1,700 patient service centres (PSCs) and 5,000 pick-up points (PUP).
Compare with Competitors


Competitors
Peer Name Market Cap.
Dr. Lal PathLabs Limited 12,576
Fortis Healthcare Limited 10,339
Thyrocare Technologies Limited 2,850
Investors
Also invests in Share %
Dr. Lal PathLabs Limited
9.2
Greenlam Industries Limited
7.9
Indian Energy Exchange Limited
4.8
La Opala RG Limited
4.6
Ceat Limited
3.6
Greenply Industries Limited
3
Also invests in Share %
La Opala RG Limited
3.6
MindTree Limited
3
Dr. Lal PathLabs Limited
2.9
Grindwell Norton Limited
2.9
Astral Poly Technik Limited
2.2
Info Edge (India) Limited
2.1
PI Industries Limited
1.9
IndusInd Bank Limited
1.6
Ajanta Pharma Limited
1.5
Larsen & Toubro Infotech
1.2
Endurance Technologies Limited
1.1
Also invests in Share %
Gateway Distriparks Limited
5
Raymond Limited
4.7
DFM Foods Limited
3.1
Ceat Limited
2.2
Ajanta Pharma Limited
2
Voltas Limited
1.9
Dr. Lal PathLabs Limited
1.7
Gulf Oil Corporation Limited
1.6
Info Edge (India) Limited
1.6
Jyothy Laboratories Limited
1.5
Price
1511.25 -37.00 (-2.39%)
Benchmarking
1804
Balance Sheet
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Profit & Loss
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Cash Flow
  • Standalone
  • Consolidated
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Ratios
= Dominant Factor
(in Rs. Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Quarterly Results
  • Standalone
  • Consolidated
(in Rs. Cr.) Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
View previous years
View fewer years
Overview
Shareholder Break-up
Trend
  • 1y
  • 2y
  • 4y
  • 5y
  • 10y
    Promoter
    Mutual Funds
    Insurance Companies
    FII
    DII Others
    Others
    Shares Pledged by Promoters(As a % of Total Promoter Holding)
Detailed
(in Rs. Cr.) Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
View previous years
View fewer years


Standalone
Consolidated
Standalone
Consolidated